$IVHI
Invech Holdings, Inc.

2024 Q3 Form 10-Q Financial Statement

#000168316824007491 Filed on October 31, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2023 Q4 2023 Q3
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $35.21K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $5.647K $35.21K $6.188K
YoY Change -8.74%
Operating Profit -$5.647K -$6.188K
YoY Change -8.74%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$35.21K
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$5.647K -$35.21K -$6.188K
YoY Change -8.74%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 10.52M shares 9.532M shares
Diluted Shares Outstanding 10.52M shares 9.532M shares

Balance Sheet

Concept 2024 Q3 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.000K
YoY Change
Cash & Equivalents $0.00 $7.000K $40.00K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $3.150K $0.00
Receivables
Other Receivables
Total Short-Term Assets $7.000K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $7.000K
Total Long-Term Assets $0.00
Total Assets $3.150K $7.000K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $5.391K $5.391K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $40.48K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $40.48K
Total Long-Term Liabilities $0.00
Total Liabilities $88.05K $40.48K
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$298.0K -$246.6K
YoY Change
Common Stock $10.52K $10.52K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$84.90K -$33.48K $1.732K
YoY Change
Total Liabilities & Shareholders Equity $3.150K $7.000K
YoY Change

Cashflow Statement

Concept 2024 Q3 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$5.647K -$35.21K -$6.188K
YoY Change -8.74%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$63.64K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 70.64K
YoY Change
NET CHANGE
Cash From Operating Activities -63.64K
Cash From Investing Activities
Cash From Financing Activities 70.64K
Net Change In Cash 7.000K
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$63.64K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001009919
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-276779
dei Entity Registrant Name
EntityRegistrantName
INVECH HOLDINGS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0419476
dei Entity Address Address Line1
EntityAddressAddressLine1
7339 E. Williams Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Unit 26496
dei Entity Address City Or Town
EntityAddressCityOrTown
Scottsdale
dei Entity Address State Or Province
EntityAddressStateOrProvince
AZ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
85255
dei City Area Code
CityAreaCode
602.793.8058
dei Local Phone Number
LocalPhoneNumber
793.8058
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
IVHI
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10521335 shares
CY2024Q3 us-gaap Cash
Cash
0 usd
CY2023Q4 us-gaap Cash
Cash
7000 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3150 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
0 usd
CY2024Q3 us-gaap Assets
Assets
3150 usd
CY2023Q4 us-gaap Assets
Assets
7000 usd
CY2024Q3 IVHI Due To Related Party
DueToRelatedParty
78214 usd
CY2023Q4 IVHI Due To Related Party
DueToRelatedParty
30641 usd
CY2024Q3 IVHI Due To Former Related Party
DueToFormerRelatedParty
4443 usd
CY2023Q4 IVHI Due To Former Related Party
DueToFormerRelatedParty
4443 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5391 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5391 usd
CY2024Q3 us-gaap Liabilities
Liabilities
88048 usd
CY2023Q4 us-gaap Liabilities
Liabilities
40475 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10521335 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10521335 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10521335 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10521335 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
10521 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
10521 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
202294 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
202294 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-298013 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-246590 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-84898 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-33475 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3150 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7000 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5647 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6188 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
51423 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
29434 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
5647 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
6188 usd
us-gaap Operating Expenses
OperatingExpenses
51423 usd
us-gaap Operating Expenses
OperatingExpenses
29434 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5647 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-6188 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-51423 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-29434 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-5647 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-6188 usd
us-gaap Net Income Loss
NetIncomeLoss
-51423 usd
us-gaap Net Income Loss
NetIncomeLoss
-29434 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10521335 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10521335 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9532324 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9532324 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10521335 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10521335 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9524998 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9524998 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-33475 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-29617 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-63092 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-16159 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-79251 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-5647 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-84898 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-9834 usd
CY2023Q1 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
-0 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
40000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-22739 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
7427 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-507 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
6920 usd
CY2023Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
1000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-6188 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1732 usd
us-gaap Net Income Loss
NetIncomeLoss
-51423 usd
us-gaap Net Income Loss
NetIncomeLoss
-29434 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
3150 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-0 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-54573 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-29434 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
47573 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
29434 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
40000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
47573 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
69434 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-7000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
40000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
40000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_844_eus-gaap--UseOfEstimates_zbyRa6leqPKd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">Use of Estimates</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84E_eus-gaap--ConcentrationRiskCreditRisk_zdTP86MwDZH7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">Concentration of Credit Risk</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments which potentially subject the Company to concentration of credit risk consist of cash deposits and customer receivables. The Company maintains cash with various major financial institutions. The Company performs periodic evaluations of the relative credit standing of these institutions. To reduce risk, the Company performs credit evaluations of its customers and maintains reserves when necessary for potential credit losses.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2024Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Convertible Preferred Stock Terms Of Conversion
ConvertiblePreferredStockTermsOfConversion
Each share of Convertible Series A Preferred Stock is convertible into 1,000 shares of common stock. In addition, the Convertible Series A Preferred Stock has voting privileges of 1,000 votes per one share of Series A. The Convertible Series A Preferred Stock is not entitled to dividend.
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
30641 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
47573 usd
CY2023Q4 us-gaap Cash
Cash
7000 usd
CY2023Q4 us-gaap Assets
Assets
7000 usd
CY2023Q4 IVHI Due To Related Party
DueToRelatedParty
30641 usd
CY2023Q4 IVHI Due To Former Related Party
DueToFormerRelatedParty
4443 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5391 usd
CY2023Q4 us-gaap Liabilities
Liabilities
40475 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
10521 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
202294 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-246590 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-33475 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7000 usd
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001683168-24-007491-index-headers.html Edgar Link pending
0001683168-24-007491-index.html Edgar Link pending
0001683168-24-007491.txt Edgar Link pending
0001683168-24-007491-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
invech_ex3101.htm Edgar Link pending
invech_ex3102.htm Edgar Link pending
invech_ex3201.htm Edgar Link pending
invech_ex3202.htm Edgar Link pending
invech_i10q-093024.htm Edgar Link pending
ivhi-20240930.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ivhi-20240930_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ivhi-20240930_def.xml Edgar Link unprocessable
ivhi-20240930_lab.xml Edgar Link unprocessable
ivhi-20240930_pre.xml Edgar Link unprocessable
invech_i10q-093024_htm.xml Edgar Link completed